Insiders · ALLR

ALLR insider transactions

Allarity Therapeutics Inc. (ALLR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ALLR

• 25d
  CEO Jensen Thomas was granted 200,000 shares, increasing direct ownership by 50% to 596,734 units (SEC Form 4)

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 27d
  Director Hoeiland Jesper was granted 25,000 shares (SEC Form 4)

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 27d
  SEC Form 3 filed by new insider Hoeiland Jesper

  3 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 31d
  Director Mclaughlin Gerald W. was granted 45,000 shares, increasing direct ownership by 180% to 70,000 units (SEC Form 4)

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 38d
  Amendment: Officer Graff Jeremy R. was granted 133,333 shares, increasing direct ownership by 54% to 381,644 units (SEC Form 4)

  4/A - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 38d
  CFO Ervin Jeffrey S was granted 150,000 shares (SEC Form 4)

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 142d
  Officer Graff Jeremy R. was granted 133,333 shares, increasing direct ownership by 54% to 381,644 units (SEC Form 4)

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 248d
  Officer Graff Jeremy R. converted options into 39,494 shares and covered exercise/tax liability with 14,613 shares (SEC Form 4)

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 329d
  SEC Form 3 filed by new insider Ervin Jeffrey S

  3 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 499d
  Amendment: SEC Form 4 filed by Director Vazzano Joseph Walter

  4/A - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 499d
  Amendment: SEC Form 4 filed by Director Benjamin Laura

  4/A - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 499d
  Amendment: SEC Form 4 filed by Director Mclaughlin Gerald W.

  4/A - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 499d
  CDO Graff Jeremy R. was granted 144,441 shares, increasing direct ownership by 122% to 262,924 units (SEC Form 4)

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 499d
  CFO Epshinsky Alexander was granted 29,496 shares, increasing direct ownership by 53% to 85,051 units (SEC Form 4)

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 499d
  CEO Jensen Thomas was granted 396,734 shares (SEC Form 4)

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 499d
  SEC Form 4 filed by Director Mclaughlin Gerald W.

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 499d
  SEC Form 4 filed by Director Vazzano Joseph Walter

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 499d
  SEC Form 4 filed by Director Benjamin Laura

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 614d
  Officer Graff Jeremy R. was granted 118,483 shares (SEC Form 4)

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 614d
  SEC Form 3 filed by new insider Graff Jeremy R.

  3 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 627d
  New insider Epshinsky Alexander claimed ownership of 55,555 shares (SEC Form 3)

  3 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 1014d
  SEC Form 3 filed by new insider Benjamin Laura

  3 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 1040d
  SEC Form 3 filed by new insider Vazzano Joseph Walter

  3 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 1343d
  SEC Form 3 filed by new insider Mclaughlin Gerald W.

  3 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 1424d
  SEC Form 4 filed by Knudsen Jens Erik

  4 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 1427d
  SEC Form 3 filed by new insider Roth David

  3 - Allarity Therapeutics, Inc. (0001860657) (Issuer)
• 1432d
  SEC Form 3 filed by new insider Brown Joan Yvonne

  3 - Allarity Therapeutics, Inc. (0001860657) (Issuer)